Your search returned 132 results.

Results
	121.	Ifosfamide-based chemotherapy for previously treated lung cancer patients. [electronic resource] by Chen, Y M Liu, J M Wu, M F Wu, H W Lin, W C Tsai, C M Perng, R P Whang-Peng, J Producer: 19980904 In: Zhonghua yi xue za zhi = Chinese medical journal; Free China ed vol. 61 Availability: No items available. Save to lists Add to cart (remove)
	122.	A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancer. [electronic resource] by Chen, Y M Perng, R P Yang, K Y Lin, W C Wu, H W Liu, J M Tsai, C M Whang-Peng, J Producer: 20000307 In: American journal of clinical oncology vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	123.	Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patients. [electronic resource] by Lai, C L Tsai, C M Tsai, T T Kuo, B I Chang, K T Fu, H T Perng, R P Chen, J Y Producer: 19990322 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 4 Availability: No items available. Save to lists Add to cart (remove)
	124.	A phase II trial of carboplatin (CBDCA) in small-cell and non-small-cell lung cancer with correlation to in vitro analysis of cytotoxicity. [electronic resource] by Dmitrovsky, E Seifter, E J Gazdar, A F Tsai, C M Edison, M Brantley, P Veach, S R Batist, G Ihde, D C Mulshine, J L Producer: 19900906 In: American journal of clinical oncology vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	125.	Molecular genetic characterization of neuroendocrine lung cancer cell lines. [electronic resource] by Lai, S L Brauch, H Knutsen, T Johnson, B E Nau, M M Mitsudomi, T Tsai, C M Whang-Peng, J Zbar, B Kaye, F J Producer: 19950623 In: Anticancer research vol. 15 Availability: No items available. Save to lists Add to cart (remove)
	126.	Phase II study of ifosfamide and etoposide chemotherapy for extensive-disease small-cell lung cancer. [electronic resource] by Chen, Y M Wu, M F Perng, R P Chou, C M Yang, K Y Lin, W C Tsai, C M Liu, J M Whang-Peng, J Producer: 19970528 In: Japanese journal of clinical oncology vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	127.	A phase II trial of vinorelbine and cisplatin in previously untreated inoperable non--small-cell lung cancer. [electronic resource] by Perng, R P Shih, J F Chen, Y M Delgado, F M Tsai, C M Chou, K C Liu, J M Chern, M S Whang-Peng, J Producer: 20000307 In: American journal of clinical oncology vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	128.	MDR1 gene expression in lung cancer. [electronic resource] by Lai, S L Goldstein, L J Gottesman, M M Pastan, I Tsai, C M Johnson, B E Mulshine, J L Ihde, D C Kayser, K Gazdar, A F Producer: 19890822 In: Journal of the National Cancer Institute vol. 81 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	129.	A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancer. [electronic resource] by Ciuleanu, T Tsai, C-M Tsao, C-J Milanowski, J Amoroso, D Heo, D S Groen, H J M Szczesna, A Chung, C-Y Chao, T-Y Middleton, G Zeaiter, A Klingelschmitt, G Klughammer, B Thatcher, N Producer: 20140609 In: Lung cancer (Amsterdam, Netherlands) vol. 82 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	130.	CNS response to osimertinib in patients with T790M-positive advanced NSCLC: pooled data from two phase II trials. [electronic resource] by Goss, G Tsai, C-M Shepherd, F A Ahn, M-J Bazhenova, L Crinò, L de Marinis, F Felip, E Morabito, A Hodge, R Cantarini, M Johnson, M Mitsudomi, T Jänne, P A Yang, J C-H Producer: 20190408 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	131.	A randomized, double-blind, placebo-controlled, phase III trial of erlotinib with or without a c-Met inhibitor tivantinib (ARQ 197) in Asian patients with previously treated stage IIIB/IV nonsquamous nonsmall-cell lung cancer harboring wild-type epidermal growth factor receptor (ATTENTION study). [electronic resource] by Yoshioka, H Azuma, K Yamamoto, N Takahashi, T Nishio, M Katakami, N Ahn, M J Hirashima, T Maemondo, M Kim, S W Kurosaki, M Akinaga, S Park, K Tsai, C M Tamura, T Mitsudomi, T Nakagawa, K Producer: 20160707 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	132.	Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer. [electronic resource] by Yang, C H Tsai, C M Wang, L S Lee, Y C Chang, C J Lui, L T Yen, S H Hsu, C Cheng, A L Liu, M Y Chiang, S C Chen, Y M Luh, K T Huang, M H Yang, P-C Perng, R-P Producer: 20020312 In: British journal of cancer vol. 86 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
1
2
3
4
5
6
7